Celldex Therapeutics, Inc. — Director's Dealing 2007

Aug 9, 2007

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AVANT IMMUNOTHERAPEUTICS INC (AVAN)
CIK: 0000744218
Period of Report: 2007-08-08

Reporting Person: PENNER HARRY JR (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2007-08-08	Non-Qualified Stock Option	$.57	A	5000	Acquired	2017-08-08	Common Stock (5000)	Direct